Novo Nordisk A/S buy RudolfL
Start price
07.03.22
/
60%
€93.01
Target price
18.07.24
€195.00
Performance (%)
109.54%
Price
12.09.23
€185.00
Summary
This prediction is currently active. With a performance of 109.54% the BUY prediction by RudolfL is a big success. A total of €9.89 was paid as dividends for this prediction. This prediction currently runs until 18.07.24. The prediction end date can be changed by RudolfL at any time. RudolfL has 60% into this predictionNovo Nordisk is a Danish pharmaceutical company that specializes in diabetes care and research. It is considered to be one of the largest companies in the world that focus exclusively on diabetes management, with a product portfolio that ranges from insulin treatment to obesity management. The company is listed on the Copenhagen Stock Exchange and has gained global recognition for its commitment to sustainable business practices and its contribution to diabetes research and treatment. Novo Nordisk has a strong financial track record and has consistently delivered solid returns to investors over the years.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Novo Nordisk A/S | - | - | - |
| iShares Core DAX® | -0.992% | -3.231% | 11.661% |
| iShares Nasdaq 100 | -0.225% | -3.339% | 36.491% |
| iShares Nikkei 225® | -0.736% | -7.859% | 18.597% |
| iShares S&P 500 | -0.509% | -2.979% | 26.341% |
Comments by RudolfL for this prediction
In the thread Novo Nordisk A/S diskutieren
Buy mit Kursziel 99,0
Kursziel geändert auf 120,0
Kursziel geändert auf 140,0
Kursziel geändert auf 170,0
Kursziel geändert auf 195,0